Why the study?
Conflicting data exist regarding which cells express IFN-lambdaR1, partly because IFNLR1 transcript levels do not always correlate with cell surface protein levels.
Population
Cell lines and primary human blood cells, including plasmacytoid dendritic cells and B cells
Comparison
Novel monoclonal antibodies tested for binding and detection of human IFN-lambdaR1
Design
In vitro laboratory study
Authors
Loading...
May refine IFN-λ therapeutic targeting; leaves open precise leukocyte subsets mediating responses.
The HLR14 monoclonal antibody enables the quantification of IFN-λR1 protein levels on cells, facilitating better characterization of cell-specific IFN-λ responses.
Weerd et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: